Overview of respiratory care for Covid-19 patients | ||||
| Sohag Medical Journal | ||||
| Article 4, Volume 24, Issue 3, July 2020, Page 23-30 PDF (296.62 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/smj.2020.33248.1168 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
bahaa mohammed refaie  1; Ebtisam Mohammed Gad2
| ||||
| 1anesthesia and ICU, faculty of medicine, Sohag university, Sohag, Egypt | ||||
| 2chest department, faculty of medicine, Sohag university, Sohag, Egypt | ||||
| Abstract | ||||
| Coronavirus disease 2019 (SARS-CoV-2) is caused by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2) which is an encapsulated coronavirus single-stranded ribonucleic acid (RNA) and is highly contagious. Transmission is believed to be predominantly through droplet spread and direct patient contact rather than 'airborne spread.' There is still no specific antiviral treatment for COVID-19 infection except for supportive therapies for affected patients including respiratory care, especially in critical cases. It has become a clinical threat to the general population worldwide since the 2019 novel outbreak of coronavirus disease originated in Wuhan, China, in late 2019. Among people infected with the novel coronavirus (SARS-CoV-2), approximately 5–15% of patients need intensive care monitoring and ventilation support. In this article, we tried to provide a practical summary of the respiratory aid for COVID-19 patients. We conducted a review of the literature through revision of the available online data on PubMed and other online resources to examine best practice recommendations concerning respiratory support for COVID-19 patients with ARDS. | ||||
| Keywords | ||||
| Corona virus; Respiratory; Intensive care; Ventilation | ||||
|
Supplementary Files
|
||||
|
Statistics Article View: 385 PDF Download: 466 |
||||
